Tocqueville Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
Other funds holding ALDR
JHIU
PHS
BFA
BB
FCMI
CAM
Tocqueville Asset Management's ALDR Position: Q4 2016 in Review
Tocqueville Asset Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2016, closing a stake of 11,650 shares — an estimated $382K sold.
Tocqueville Asset Management first reported a position in ALDR in Q2 2015 and held it in 6 quarters. The position peaked at $715K in Q2 2015. 145 funds tracked by Wall St. Rank hold ALDR as of Q4 2016.
- Tocqueville Asset Management reported no remaining Alder Biopharmaceuticals position as of Q4 2016 after selling out during the quarter.
- Tocqueville Asset Management sold 11,650 Alder Biopharmaceuticals shares in Q4 2016, an estimated $382K.
- Tocqueville Asset Management first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 6 quarters.
- Tocqueville Asset Management's Alder Biopharmaceuticals position peaked at $715K in Q2 2015.
- 145 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2016.
Based on Tocqueville Asset Management's 13F filing for Q4 2016, filed 30 Jan 2017.